MedTrace Logo

Arthroscopic Rotator Cuff Repair Augmented With Platelet Rich Plasma

NCT04703998 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 103

Last updated 2022-12-22

No results posted yet for this study

Summary

Purpose: To assess whether the use of platelet-rich plasma used as an adjuvant to arthroscopic rotator cuff repairs modify the rate of re-tears (measured by MRI) compared to a control group that only underwent the isolated arthroscopic repair. Hypothesis: Platelet rich plasma used as an adjuvant to arthroscopic rotator cuff repairs decrease the rate of retears.

Conditions

  • Rotator Cuff Tears

Interventions

PROCEDURE

Arthroscopic rotator cuff repair

A double-row rotator cuff repair will be performed.

BIOLOGICAL

platelet rich plasma

A single dose of 10 ml of autologous platelet rich plasma at the bone-tendon interfase will be administered.

Sponsors & Collaborators

  • Hospital Italiano de Buenos Aires

    lead OTHER

Principal Investigators

  • Luciano Rossi, MD · Hospital Italiano de Buenos Aires

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-03
Primary Completion
2022-09-01
Completion
2022-09-01

Countries

  • Argentina

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04703998 on ClinicalTrials.gov